"I will not allow Big Pharma to operate above the law or put their greed ahead of Texans’ well-being," said Paxton.

Kenvue (KVUE) keeps drifting lower even after reporting steady revenue and profit growth, which raises a simple question for ...

Kimberly-Clark (KMB) stock faces risks from the $48.7B Kenvue acquisition, high debt, and weak growth. Learn why analysts ...

KVUE's stock performance has suffered from legacy investor selling, management turnover, litigation risks, and a profit ...

This was the stock's second consecutive day of gains.

Kenvue Inc. (KVUE), a maker of consumer health products including pain reliever Tylenol, was a notable detractor. Read more ...

November's announced M&A deals of more than $10 billion in transaction value brought the fourth quarter's worldwide tally to ...

Dividend Kings remain largely overvalued, but six—including MO, UVV, HRL, KVUE, CDUAF, and UBSI—are now fairly priced with ...

Kimberly-Clark (Nasdaq: KMB) is acquiring Kenvue (NYSE: KVUE), creating a health and wellness giant with $32 billion in revenue, and 10 brands generating over $1 billion in annual sales each (such as ...

GS Equity Income Fund underperformed in Q3. Discover key contributors like Oracle & J&J, and detractors Kenvue & Honeywell.

Given the potential for a sizable sell-off, it makes sense for investors to move to S&P 500 Dividend Aristocrat stocks like ...

These five top blue chip dividend stocks offer growth and income investors a solid opportunity to generate passive income and total return.